Canopy Growth Corporation vs Eli Lilly & Co.
CGC vs LLY — side-by-side comparison from reported financials. CGC leads 1, LLY leads 8 of 9 comparable metrics.
Canopy Growth Corporation
CGC · Healthcare
$0.84-0.80%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | CGC | LLY |
|---|---|---|
| Price | $0.84 | $1 177.20 |
| Market cap | $360M | $1.05T |
| Revenue (TTM) | $285M | $79.7B |
| Revenue growth | -10.9% | +31.7% |
| Net margin | -92.4% | 33.5% |
| Free cash flow | -$69.1M | $18.2B |
| Net cash (debt) | $148M | ($35.2B) |
| 1-year price return | -49.1% | +37.6% |
| P/E | — | 41.6 |
| P/E vs own history (cheap-side %) | — | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | -33% | 93% |
| Altman Z-score | -13.41 | 7.10 |
| CV checks passed | 3 of 9 | 11 of 9 |
| Employees | 1,128 | 50,000 |
Full résumé-style profiles: CGC CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.